Cisplatin induced nephrotoxicity. Acute kidney failure, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In addition to routine treatments, this group consumes one turmeric tablet of "Dineh Iran" company (Each tablet contains 450 mg of turmeric rhizome powder and 50 mg
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18-60 years Confirmation of cancer by a specialist doctor The disease should be such that the use of cisplatin as a treatment is approved by a specialist doctor
Exclusion criteria
Exclusion criteria: The patient has a previous kidney disease (GFR is low from the beginning) Existence of underlying diseases such as diabetes, hypertension, etc. in the patient Increased creatinine indicated for discontinuation of the drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood creatinine level. Timepoint: Before starting treatment with Cisplatin and 5 and 21 days after starting treatment with Cisplatin. Method of measurement: Biorexfars Laboratory Diagnostic Kit.;BUN(Blood Urea Nitrogen) level. Timepoint: Before starting treatment with Cisplatin and 5 and 21 days after starting treatment with Cisplatin. Method of measurement: Biorexfars Laboratory Diagnostic Kit.;Creatinine Clearance level. Timepoint: Before starting treatment with Cisplatin and 5 and 21 days after starting treatment with Cisplatin. Method of measurement: Through Up-to-date software and using the CKD-EPI formula. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Amir Sarabi
Semnan University of Medical Sciences
Outcome results
None listed